Masimo board authorizes evaluation of consumer business separation; retains healthcare

MASIMO CORP

Board authorized management to evaluate separation of consumer business (audio + health products: Stork, Freedom).
Masimo will retain professional healthcare and telehealth products; expects improved profitability.
Joe Kiani to remain Chairman and CEO of Masimo and become Chairman of the new company.
Separation timing subject to due diligence, definitive agreements, SEC clearance, and regulatory approvals.
Masimo reaffirms Q1 and fiscal 2024 financial guidance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.